Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology to provide personalized insight into the therapy response. By combining proven approaches to measuring DNA with cutting-edge technology to improve accuracy and sensitivity Cadex Genomics provides unique insight into therapy response using simple blood draws.
Alibrex is a blood-based assay, developed to help physicians identify patients who are not responding to drug therapy. The test is optimized to maximize NPV, that is, minimize the number of false non-responders.
Company Details
- Employees
- 3
- Founded
- 2018
- Address
- 1615 Poydras St, New Orleans,louisiana 70112,united States
- Phone
- 650-292-2819
- bh****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cadexgenomics.com
- HQ
- New Orleans, Louisiana
Cadex Genomics Questions
Cadex Genomics's helpline number is 650-292-2819
Cadex Genomics's website is cadexgenomics.com
Cadex Genomics's LinkedIn profile is https://www.linkedin.com/company/cadexgenomics
Cadex Genomics has
3 employees.
View email and phone details for 3
employees at Cadex Genomics.
Cadex Genomics's industry is
Biotechnology Research
Cadex Genomics's top competitors are
Guardant Health,
Cognitive Genetics Institute,
Co-Diagnostics, Inc,
Pathwork Diagnostics,
Angel Biotech,
Phaeno Biotech,
Delfi Diagnostics,
Visby Medical,
Clongen Laboratories, Llc,
Burning Rock Dx.
Cadex Genomics's support email address is bhaack@cadexgenomics.com
Cadex Genomics's categories are Biotechnology Research
Cadex Genomics's founding year is 2018
